{"count": 14, "results": [{"_id": "35602825", "pmid": 35602825, "pmcid": "PMC9117863", "title": "Metformin-Associated Lactic Acidosis: A Case Report and Review", "journal": "Cureus", "authors": ["Ashraf S", "Upreti P", "Karki S", "Khan M", "Nasr R"], "date": "2022-04-17T00:00:00Z", "doi": "10.7759/cureus.24220", "meta_date_publication": "2022 Apr", "meta_volume": "14", "meta_issue": "4", "meta_pages": "e24220", "score": 50266.504, "text_hl": "Here, we discuss a 53-year-old female with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type II diabetes mellitus@@@ on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ who presented to the emergency department (ED) with chief complaints of @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ and @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@lightheadedness@@@ and was later diagnosed with @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@.", "citations": {"NLM": "Ashraf S, Upreti P, Karki S, Khan M, Nasr R. Metformin-Associated Lactic Acidosis: A Case Report and Review Cureus. 2022 Apr;14(4):e24220. PMID: 35602825", "BibTeX": "@article{35602825, title={Metformin-Associated Lactic Acidosis: A Case Report and Review}, author={Ashraf S and Upreti P and Karki S and Khan M and Nasr R}, journal={Cureus}, volume={14}, number={4}, pages={e24220}}"}}, {"_id": "35503625", "pmid": 35503625, "title": "Efficacy and safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Ding Y", "Liu Y", "Qu Y", "Lin M", "Dong F", "Li Y", "Cao L", "Lin S"], "date": "2022-04-01T00:00:00Z", "doi": "10.26355/eurrev_202204_28611", "meta_date_publication": "2022 Apr", "meta_volume": "26", "meta_issue": "8", "meta_pages": "2802-2817", "score": 50256.4, "text_hl": "In terms of safety, the @CHEMICAL_Vildagliptin @CHEMICAL_MESH:D000077597 @@@vildagliptin@@@ plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as combination therapy did not increase risk of total adverse events (AEs) [RR=0.98, 95% CI (0.94,1.02), p=0.29], however there were significant statistical difference and did not increase the risk of @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ [RR=0.55, 95% CI (0.40, 0.76), p=0.0003] and @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@Gastrointestinal (GI) disorders@@@ [RR=0.72, 95% CI (0.58, 0.91), p=0.006], but significantly increased risk of @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ [RR=1.41, 95% CI (1.06, 1.88), p=0.02] when compared with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy. ", "citations": {"NLM": "Ding Y, Liu Y, Qu Y, Lin M, Dong F, Li Y, Cao L, Lin S. Efficacy and safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis. Eur Rev Med Pharmacol Sci. 2022 Apr;26(8):2802-2817. PMID: 35503625", "BibTeX": "@article{35503625, title={Efficacy and safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis.}, author={Ding Y and Liu Y and Qu Y and Lin M and Dong F and Li Y and Cao L and Lin S}, journal={Eur Rev Med Pharmacol Sci}, volume={26}, number={8}, pages={2802-2817}}"}}, {"_id": "36131550", "pmid": 36131550, "title": "Metformin for the Treatment of Recurrent Respiratory Papillomatosis.", "journal": "Ann Otol Rhinol Laryngol", "authors": ["Din-Lovinescu C", "Blitzer A"], "date": "2022-09-21T00:00:00Z", "doi": "10.1177/00034894221125002", "meta_date_publication": "2022 Sep 21", "meta_volume": "", "meta_issue": "", "meta_pages": "34894221125002", "score": 50255.99, "text_hl": "All @SPECIES_9606 @@@patients@@@ tolerated @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ well with only minor side effects of self-limiting @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@light-headedness@@@, @DISEASE_Flushing @DISEASE_MESH:D005483 @@@facial flushing@@@ or @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal upset@@@. ", "citations": {"NLM": "Din-Lovinescu C, Blitzer A. Metformin for the Treatment of Recurrent Respiratory Papillomatosis. Ann Otol Rhinol Laryngol. 2022 Sep 21;():34894221125002. PMID: 36131550", "BibTeX": "@article{36131550, title={Metformin for the Treatment of Recurrent Respiratory Papillomatosis.}, author={Din-Lovinescu C and Blitzer A}, journal={Ann Otol Rhinol Laryngol}, pages={34894221125002}}"}}, {"_id": "37715272", "pmid": 37715272, "pmcid": "PMC10504777", "title": "Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report", "journal": "J Med Case Rep", "authors": ["Ariga M", "Hagita J", "Soda M", "Oida Y", "Teramachi H", "Kitaichi K"], "date": "2023-09-16T00:00:00Z", "doi": "10.1186/s13256-023-04136-0", "meta_date_publication": "2023 Sep 16", "meta_volume": "17", "meta_issue": "1", "meta_pages": "393", "score": 50243.695, "text_hl": "A 60-year-old Japanese man with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type II diabetes@@@, who was taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (500 mg three times a day) along with several other medications, visited the emergency department with @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@, malaise, and @DISEASE_Oliguria @DISEASE_MESH:D009846 @@@oliguria@@@. ", "citations": {"NLM": "Ariga M, Hagita J, Soda M, Oida Y, Teramachi H, Kitaichi K. Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report J Med Case Rep. 2023 Sep 16;17(1):393. PMID: 37715272", "BibTeX": "@article{37715272, title={Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report}, author={Ariga M and Hagita J and Soda M and Oida Y and Teramachi H and Kitaichi K}, journal={J Med Case Rep}, volume={17}, number={1}, pages={393}}"}}, {"_id": "32212801", "pmid": 32212801, "pmcid": "PMC7437343", "title": "Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-Blind Placebo-Controlled Trial", "journal": "Asian Pac J Cancer Prev", "authors": ["Petchsila K", "Prueksaritanond N", "Insin P", "Yanaranop M", "Chotikawichean N"], "date": "2020-03-01T00:00:00Z", "doi": "10.31557/APJCP.2020.21.3.733", "meta_date_publication": "2020 Mar 1", "meta_volume": "21", "meta_issue": "3", "meta_pages": "733-741", "score": 50242.85, "text_hl": "The metabolic effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was also evaluated by a recording of fasting @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood sugar@@@, HbA1C and potential adverse events including @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@, and @DISEASE_hypoglycemic_encephalopathy @DISEASE_MESH:C000721848 @@@hypoglycemic symptom@@@. ", "citations": {"NLM": "Petchsila K, Prueksaritanond N, Insin P, Yanaranop M, Chotikawichean N. Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-Blind Placebo-Controlled Trial Asian Pac J Cancer Prev. 2020 Mar 1;21(3):733-741. PMID: 32212801", "BibTeX": "@article{32212801, title={Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-Blind Placebo-Controlled Trial}, author={Petchsila K and Prueksaritanond N and Insin P and Yanaranop M and Chotikawichean N}, journal={Asian Pac J Cancer Prev}, volume={21}, number={3}, pages={733-741}}"}}, {"_id": "34302410", "pmid": 34302410, "title": "In silico studies: Physicochemical properties, drug score, toxicity predictions and molecular docking of organosulphur compounds against Diabetes mellitus.", "journal": "J Mol Recognit", "authors": ["Rajalakshmi R", "Lalitha P", "Sharma SC", "Rajiv A", "Chithambharan A", "Ponnusamy A"], "date": "2021-11-01T00:00:00Z", "doi": "10.1002/jmr.2925", "meta_date_publication": "2021 Nov", "meta_volume": "34", "meta_issue": "11", "meta_pages": "e2925", "score": 50235.05, "text_hl": "The commercially available anti-diabetic drugs in the market include @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonyl urea@@@, @CHEMICAL_meglitinide @CHEMICAL_MESH:C030516 @@@meglitinides@@@, @CHEMICAL_miglitol @CHEMICAL_MESH:C045621 @@@miglitol@@@, @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@acarbose@@@, @CHEMICAL_Biguanides @CHEMICAL_MESH:D001645 @@@biguanides@@@, and @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@ cause side effects like hypoglycaemia, @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@, @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@liver cell injury@@@, digestive discomfort, @DISEASE_Nervous_System_Malformations @DISEASE_MESH:D009421 @@@neurological defects@@@, etc. ", "citations": {"NLM": "Rajalakshmi R, Lalitha P, Sharma SC, Rajiv A, Chithambharan A, Ponnusamy A. In silico studies: Physicochemical properties, drug score, toxicity predictions and molecular docking of organosulphur compounds against Diabetes mellitus. J Mol Recognit. 2021 Nov;34(11):e2925. PMID: 34302410", "BibTeX": "@article{34302410, title={In silico studies: Physicochemical properties, drug score, toxicity predictions and molecular docking of organosulphur compounds against Diabetes mellitus.}, author={Rajalakshmi R and Lalitha P and Sharma SC and Rajiv A and Chithambharan A and Ponnusamy A}, journal={J Mol Recognit}, volume={34}, number={11}, pages={e2925}}"}}, {"_id": "34059533", "pmid": 34059533, "title": "Rare case of diabetic neuropathic cachexia along with diabetic amyotrophy.", "journal": "BMJ Case Rep", "authors": ["Khan ZU", "Ghuman N", "Mak K"], "date": "2021-05-31T00:00:00Z", "doi": "10.1136/bcr-2020-239869", "meta_date_publication": "2021 May 31", "meta_volume": "14", "meta_issue": "5", "meta_pages": "", "score": 50231.305, "text_hl": "A 65-year-old @SPECIES_9606 @@@patient@@@ with background of @CHEMICAL_Alcohols @CHEMICAL_MESH:D000438 @@@alcohol@@@ excess and previous @DISEASE_Wounds_Gunshot @DISEASE_MESH:D014948 @@@gunshot wounds@@@ was admitted with significant @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@, @DISEASE_Muscle_Cramp @DISEASE_MESH:D009120 @@@leg cramps@@@, @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ and @DISEASE_Lethargy @DISEASE_MESH:D053609 @@@lethargy@@@ for the last 3 months. ", "citations": {"NLM": "Khan ZU, Ghuman N, Mak K. Rare case of diabetic neuropathic cachexia along with diabetic amyotrophy. BMJ Case Rep. 2021 May 31;14(5):. PMID: 34059533", "BibTeX": "@article{34059533, title={Rare case of diabetic neuropathic cachexia along with diabetic amyotrophy.}, author={Khan ZU and Ghuman N and Mak K}, journal={BMJ Case Rep}, volume={14}, number={5}}"}}, {"_id": "39356039", "pmid": 39356039, "title": "Interventions for preventing the progression of autosomal dominant polycystic kidney disease.", "journal": "Cochrane Database Syst Rev", "authors": ["St Pierre K", "Cashmore BA", "Bolignano D", "Zoccali C", "Ruospo M", "Craig JC", "Strippoli GF", "Mallett AJ", "Green SC", "Tunnicliffe DJ"], "date": "2024-10-02T00:00:00Z", "doi": "10.1002/14651858.CD010294.pub3", "meta_date_publication": "2024 Oct 2", "meta_volume": "10", "meta_issue": "10", "meta_pages": "CD010294", "score": 50216.438, "text_hl": "Somatostatin analogues probably increase @DISEASE_Alopecia @DISEASE_MESH:D000505 @@@alopecia@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@ or @DISEASE_Abnormalities_Drug_Induced @DISEASE_MESH:D000014 @@@abnormal faeces@@@, @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ and @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@ but may have little or no effect on @DISEASE_Anemia_Hemolytic @DISEASE_MESH:D000743 @@@anaemia@@@ or @DISEASE_Infections @DISEASE_MESH:D007239 @@@infection@@@. ", "citations": {"NLM": "St Pierre K, Cashmore BA, Bolignano D, Zoccali C, Ruospo M, Craig JC, Strippoli GF, Mallett AJ, Green SC, Tunnicliffe DJ. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. PMID: 39356039", "BibTeX": "@article{39356039, title={Interventions for preventing the progression of autosomal dominant polycystic kidney disease.}, author={St Pierre K and Cashmore BA and Bolignano D and Zoccali C and Ruospo M and Craig JC and Strippoli GF and Mallett AJ and Green SC and Tunnicliffe DJ}, journal={Cochrane Database Syst Rev}, volume={10}, number={10}, pages={CD010294}}"}}, {"_id": "31338110", "pmid": 31338110, "pmcid": "PMC6629602", "title": "Transient Blindness in a Patient with Severe Metformin-Associated Lactic Acidosis (MALA)", "journal": "Electrolyte Blood Press", "authors": ["Jeon JW", "Choi W", "Kim HR", "Ham YR", "Choi DE", "Na KR", "Lee KW", "Bae SY", "Kim SH"], "date": "2019-06-01T00:00:00Z", "doi": "10.5049/EBP.2019.17.1.16", "meta_date_publication": "2019 Jun", "meta_volume": "17", "meta_issue": "1", "meta_pages": "16-20", "score": 50047.84, "text_hl": "He experienced @DISEASE_Postoperative_Nausea_and_Vomiting @DISEASE_MESH:D020250 @@@nausea, vomiting@@@, and @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ afterward. His medical history included @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, and the latter was treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Jeon JW, Choi W, Kim HR, Ham YR, Choi DE, Na KR, Lee KW, Bae SY, Kim SH. Transient Blindness in a Patient with Severe Metformin-Associated Lactic Acidosis (MALA) Electrolyte Blood Press. 2019 Jun;17(1):16-20. PMID: 31338110", "BibTeX": "@article{31338110, title={Transient Blindness in a Patient with Severe Metformin-Associated Lactic Acidosis (MALA)}, author={Jeon JW and Choi W and Kim HR and Ham YR and Choi DE and Na KR and Lee KW and Bae SY and Kim SH}, journal={Electrolyte Blood Press}, volume={17}, number={1}, pages={16-20}}"}}, {"_id": "16330295", "pmid": 16330295, "title": "Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study.", "journal": "Clin Ther", "authors": ["Rao N", "Chou T", "Ventura D", "Abramowitz W"], "date": "2005-10-01T00:00:00Z", "doi": "10.1016/j.clinthera.2005.10.006", "meta_date_publication": "2005 Oct", "meta_volume": "27", "meta_issue": "10", "meta_pages": "1596-606", "score": 50041.57, "text_hl": "No significant pharmacokinetic or pharmacodynamic interactions were observed between @CHEMICAL_Memantine @CHEMICAL_MESH:D008559 @@@memantine@@@ and @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glyburide@@@/@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. Adverse events included @<m>DISEASE_Dizziness</m> @DISEASE_MESH:D004244 @@@dizziness@@@ (41.7% of @SPECIES_9606 @@@patients@@@) with @CHEMICAL_Memantine @CHEMICAL_MESH:D008559 @@@memantine@@@ administration and @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal effects@@@ (@DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, 9.1 %; @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, 9.1%; @DISEASE_Colic @DISEASE_MESH:D003085 @@@abdominal cramps@@@, 13.6%) with @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glyburide@@@/@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration. ", "citations": {"NLM": "Rao N, Chou T, Ventura D, Abramowitz W. Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study. Clin Ther. 2005 Oct;27(10):1596-606. PMID: 16330295", "BibTeX": "@article{16330295, title={Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study.}, author={Rao N and Chou T and Ventura D and Abramowitz W}, journal={Clin Ther}, volume={27}, number={10}, pages={1596-606}}"}}]}